Consistent Glycemic Efficacy and Safety of Concomitant Use of iGlarLixi and Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Type 2 Diabetes-A Patient-Level Pooled Analysis

被引：0
|
作者：
Giorgino, Francesco
Guja, Cristian
Davies, Melanie J.
Aydin, Hasan
Lauand, Felipe
Souhami, Elisabeth
Melas-Melt, Lydie
Aroda, Vanita R.
Rosenstock, Julio
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-773-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
773-P
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Empagliflozin: A sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes
    Dixit, Divisha
    Yoon, Youngmin
    Volino, Lucio R.
    Mansukhani, Rupal Patel
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (22) : 1943 - 1954
  • [32] The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Type 2 Diabetes Mellitus
    Taylor, Shawn Riser
    Harris, Kira B.
    PHARMACOTHERAPY, 2013, 33 (09): : 984 - 999
  • [33] Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetes
    Hedrington, Maka S.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (04) : 613 - 623
  • [34] Sodium-Glucose Cotransporter-2 Inhibitor Prevents Stroke in Patients With Diabetes and Atrial Fibrillation
    Chang, Sheng-Nan
    Chen, Jien-Jiun
    Huang, Pang-Shuo
    Wu, Cho-Kai
    Wang, Yi-Chih
    Hwang, Juey-Jen
    Tsai, Chia-Ti
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [35] Increased risk of erythrocytosis in men with type 2 diabetes treated with combined sodium-glucose cotransporter-2 inhibitor and testosterone replacement therapy
    Gosmanov, A. R.
    Gemoets, D. E.
    Schumacher, K. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (10) : 2615 - 2621
  • [36] Dapagliflozin: A Once-Daily Oral Therapy Sodium-Glucose Cotransporter-2 Inhibitor for the Treatment of Adult Patients with Type 2 Diabetes
    Jadoon, Khalid
    Idris, Iskandar
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 185 - 194
  • [37] Perioperative Implication of Sodium-glucose Cotransporter-2 Inhibitor in a Patient following Major Surgery
    Vadi, Sonali
    Lad, Vidhyadhar
    Kapoor, Dheeraj
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (08) : 959 - 960
  • [38] Sodium-glucose cotransporter-2 inhibitors use and risk of dementia in different ethnoracial groups with type 2 diabetes
    Yang, Shih-Chi
    Liao, Wen-Chieh
    Jhang, Yi-Sheng
    Chang, Hui-Chin
    Su, Yu-Jung
    Chen, Shiu-Jau
    Gau, Shuo-Yan
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)
  • [39] Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Solid Organ Transplant Recipients
    Sweiss, Helen
    Selznick, Leah
    Contreras, Jillian
    Long, Christina
    Hall, Reed
    Bhayana, Suverta
    Patel, Rupal
    Klein, Kelsey
    PROGRESS IN TRANSPLANTATION, 2023, 33 (03) : 261 - 265
  • [40] Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial
    Lam, Carolyn S. P.
    Ramasundarahettige, Chinthanie
    Branch, Kelley R. H.
    Sattar, Naveed
    Rosenstock, Julio
    Pratley, Richard
    Del Prato, Stefano
    Lopes, Renato D.
    Niemoeller, Elisabeth
    Khurmi, Nardev S.
    Baek, Seungjae
    Gerstein, Hertzel C.
    CIRCULATION, 2022, 145 (08) : 565 - 574
12345